Clinical Trials Directory

Trials / Completed

CompletedNCT02569905

Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering

Tumor Hospital of Guangxi Medical University, China

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
166 (actual)
Sponsor
Guangxi Medical University · Academic / Other
Sex
All
Age
21 Years – 62 Years
Healthy volunteers
Accepted

Summary

Shivering is an early postoperative complication during the postoperative recovery period, and there is no clear consensus about the best way for its prevention. The aim of the study was to compare the efficacy and accompanying side effects of prophylactic flurbiprofen with that of parecoxib or placebo for reducing postoperative shivering.

Detailed description

154 patients with American Society of Anesthesiologists physical status I-II, who were scheduled for colorectal operation under general anesthesia, were randomly assigned to receive flurbiprofen (Group F), parecoxib sodium (Group P ) or normal saline(Group S)40min before the end of surgery. Hemodynamic parameters were monitored. The occurrence of shivering postoperative nausea and vomiting were recorded during the recovery period. And visual analogue score (VAS) and ramsy sedation scale (RSS) were also recorded.

Conditions

Interventions

TypeNameDescription
DRUGparecoxib sodiumparecoxib sodium 40mg
DRUGflurbiprofenflurbiprofen 50mg
DRUGsalinenormal saline

Timeline

Start date
2014-04-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2015-10-07
Last updated
2015-10-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02569905. Inclusion in this directory is not an endorsement.